ADNCX
Price
$20.62
Change
+$0.45 (+2.23%)
Updated
Jun 18 closing price
Net Assets
169.87M
VMGIX
Price
$120.37
Change
+$1.91 (+1.61%)
Updated
Jun 18 closing price
Net Assets
33.76B
Interact to see
Advertisement

ADNCX vs VMGIX

ADNCX vs VMGIX Comparison Chart in %
View a ticker or compare two or three
VS
ADNCX vs. VMGIX commentary
Jun 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNCX is a Hold and VMGIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMGIX has more cash in the bank: 33.8B vs. ADNCX (170M). VMGIX pays higher dividends than ADNCX: VMGIX (0.50) vs ADNCX (0.00). ADNCX was incepted earlier than VMGIX: ADNCX (7 years) vs VMGIX (20 years). ADNCX (2.38) is less costly to investors than VMGIX (0.19). ADNCX is a more actively managed with annual turnover of: 46.00 vs. VMGIX (17.00). ADNCX has a lower initial minimum investment than VMGIX: ADNCX (1000) vs VMGIX (3000). ADNCX annual gain was more profitable for investors over the last year : 21.01 vs. VMGIX (12.60). VMGIX return over 5 years is better than : 34.63 vs. ADNCX (-51.98).
ADNCXVMGIXADNCX / VMGIX
Total Expense Ratio2.160.191,137%
Annual Report Gross Expense Ratio2.380.191,253%
Fund Existence7 years20 years-
Gain YTD5.4199.67056%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets170M33.8B1%
Annual Yield % from dividends0.000.50-
Returns for 1 year21.0112.60167%
Returns for 3 years79.6251.30155%
Returns for 5 years-51.9834.63-150%
Returns for 10 yearsN/A203.59-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RUNTX30.730.54
+1.79%
Russell Inv US Small Cap Equity M
HHCZX16.940.15
+0.89%
NexPoint Event Driven Z
MRSHX28.420.22
+0.78%
MFS Research International R3
PICRX44.380.24
+0.54%
Putnam International Small Cap R
FHCIX64.570.17
+0.26%
Fidelity Advisor Health Care I